Armis Advisers’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.9M Buy
43,675
+3,339
+8% +$136K 0.16% 104
2026
Q2
$1.66M Buy
40,336
+2,612
+7% +$102K 0.15% 109
2026
Q1
$1.51M Buy
37,724
+6,972
+23% +$264K 0.15% 108
2025
Q4
$1.06M Buy
+30,752
New +$1.18M 0.12% 134

Other funds holding HCMT

Armis Advisers's HCMT Position: Q3 2026 in Review

Armis Advisers increased its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 8.3% in Q3 2026, buying an estimated $136K and bringing the position to 43,675 shares worth $1.9M. The position accounts for 0.16% of the portfolio, ranked #104.

Armis Advisers first reported a position in HCMT in Q4 2025 and has held it in 4 quarters since. 7 funds tracked by Wall St. Rank hold HCMT as of Q3 2026.

  • Armis Advisers held 43,675 shares of Direxion HCM Tactical Enhanced US ETF worth $1.9M as of Q3 2026.
  • Armis Advisers bought 3,339 Direxion HCM Tactical Enhanced US ETF shares in Q3 2026, an estimated $136K.
  • Direxion HCM Tactical Enhanced US ETF made up 0.16% of Armis Advisers's portfolio in Q3 2026, its #104 holding.
  • Armis Advisers first reported a position in Direxion HCM Tactical Enhanced US ETF in Q4 2025 and has held it in 4 quarters since.
  • 7 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.